Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 394

Results For "SSI"

5608 News Found

India Health Link join hands with Canopi
Supply Chain | July 16, 2022

India Health Link join hands with Canopi

To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India


CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
News | July 15, 2022

CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine

Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.


Philips highlights AI-powered precision diagnosis portfolio at ECR 2022
Digitisation | July 15, 2022

Philips highlights AI-powered precision diagnosis portfolio at ECR 2022

Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes


Shilpa Medicare’s Unit VI, Bengaluru facility has been issued UK MHRA GMP
Drug Approval | July 14, 2022

Shilpa Medicare’s Unit VI, Bengaluru facility has been issued UK MHRA GMP

The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements


Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
Clinical Trials | July 14, 2022

Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.


Heathcare startup MedTel to raise around USD 10mn in Series A
News | July 13, 2022

Heathcare startup MedTel to raise around USD 10mn in Series A

MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.


Eversana partners with Compai Pharma to expand commercialisation services across APAC
News | July 13, 2022

Eversana partners with Compai Pharma to expand commercialisation services across APAC

EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners


Athos announces research collaboration to advance precision medicine in inflammatory bowel disease
News | July 13, 2022

Athos announces research collaboration to advance precision medicine in inflammatory bowel disease

Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples


ProBioGen partners with Granite Bio for cell line development and GMP manufacturing services
News | July 13, 2022

ProBioGen partners with Granite Bio for cell line development and GMP manufacturing services

Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B


Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7
News | July 12, 2022

Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7

The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds